The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Tayupova G.N.

Kuvatova Republican Clinical Hospital, Ufa, Russia

Saitgareeva A.R.

Republic Consultative Diagnostic Centre of the Extrapyramidal Pathology and the Botulinotherapy LLC «Medstandart», Ufa, Russia

Bajtimerov A.R.

RB City Hospital №21, Ufa, Russia

Levin O.S.

Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia

Transcranial magnetic stimulation in Parkinson’s disease

Authors:

Tayupova G.N., Saitgareeva A.R., Bajtimerov A.R., Levin O.S.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(6‑2): 82‑87

DOI: 10.17116/jnevro20161166282-87

Read: 6660 times

Download PDF (RU)
Contact the author
Table of contents

TRANSCRANIAL MAGNETIC STIMULATION IN PARKINSON’S DISEASE
TRANSCRANIAL MAGNETIC STIMULATION IN PARKINSON’S DISEASE

To cite this article:

Tayupova GN, Saitgareeva AR, Bajtimerov AR, Levin OS. Transcranial magnetic stimulation in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(6‑2):82‑87. (In Russ.)
https://doi.org/10.17116/jnevro20161166282-87

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Diagnosis and treatment approaches for sialorrhea in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):29-34
Reso­lution of the expert council «Possibilities of neuroprotective therapy in patients with arte­rial hype­rtension and cognitive diso­rders». Russian Journal of Preventive Medi­cine. 2024;(11):85-93
The gut microbiota in bipo­lar diso­rder. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):28-33
Neurochemical mechanisms of tremor in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):64-72
Clinical presentation and diagnosis of Parkinson’s disease in patients with schi­zophrenia spectrum diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):73-80
Cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):81-90
Bladder dysfunction in patients with stages I—III of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):91-99
Chro­nic epidural spinal cord stimulation for gait impairments in Parkinson’s disease and atypical parkinsonism. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):100-112
Como­rbidity of depression and deme­ntia: epidemiological, biological and therapeutic aspe­cts. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):113-121
Online phenotypes of depression symptoms are asso­ciated with poly­genic risk scores of soma­tic diseases in a popu­lation-based cohort. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):122-131
Abstract:

This review presents the results of studies investigating the effects of transcranial magnetic stimulation (TKMS) on motor and non-motor symptoms of Parkinson’s disease (PD). It has been found that TKMS reduces the severity of both motor and non-motor disorders without causing serious side-effects. Magnetic field therapy can be combined with pharmacological and non-drug therapies, including the use of dopaminergic therapy, antidepressants and anti-dementia drugs, as well as stereotactic operations. It is necessary to continue the study of the influence of TKMS on the severity of PD symptoms using different electromagnetic characteristics.

Keywords:

Parkinson’s disease
transcranial magnetic stimulation
TKMS
movement disorders
non-motor symptoms
depression
dementia
cognitive impairment

Authors:

Tayupova G.N.

Kuvatova Republican Clinical Hospital, Ufa, Russia

Saitgareeva A.R.

Republic Consultative Diagnostic Centre of the Extrapyramidal Pathology and the Botulinotherapy LLC «Medstandart», Ufa, Russia

Bajtimerov A.R.

RB City Hospital №21, Ufa, Russia

Levin O.S.

Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia

Close metadata

References:

  1. Litvienko I.V. Bolezn' Parkinsona. M.: Miklosh; 2010.
  2. Levin O.S., Dokadina L.V. Epidemiologiya parkinsonizma i bolezni Parkinsona. Nevrologicheskii zhurnal. 2005;5:41-49.
  3. de Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006;5(6):525-535. doi: org/10.1016/s1474-4422(06)70471-9
  4. Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of Parkinson’s disease: a review of the evidence. Eur J Epidemiol. 2011;26(suppl 1):1-58. doi: 10.1007/s10654-011-9581-6
  5. Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM. Projected number of people with Parkinson’s disease in the most populous nations, 2005 through 2030. Neurology. 2007;68(5):384-386. doi: org/10.1212/01.wnl.0000247740.47667.03
  6. Symptomatic pharmacological therapy in Parkinson’s disease. Parkinson’s Disease. The National Collaborating Centre for Chronic Conditions. London: Royal College of Physicians; 2006;59-100.
  7. Yakhno N.N., Nodel' M.R. Sovremennye printsipy terapii bolezni Parkinsona. Regulyarnye vypuski «RMZh». 2000;10:418.
  8. Schrag A, Quinn N. Dyskinesias and motor fluctuations in Parkinson's disease: a community-based study. Brain. 2000;123(11):2297-2305.
  9. Shtok V.N., Levin O.S., Fedorova N.V. Ekstrapiramidnye rasstroistva: Klassifikatsiya, terminologiya, diagnostika, lechenie. Rukovodstvo dlya vrachei. Izd. 2-e, pererab., dop., 2002.
  10. Yu H, Neimat JS. The treatment of movement disorders by deep brain stimulation. Neurotherapeutics. 2008;5:26. doi: 10.1016/j.nurt.2007.10.072
  11. Illarioshkin S.N., Ivanova-Smolenskaya I.A. Drozhatel'nyegiperkinezy. Rukovodstvo dlya vrachei. M. 2011.
  12. Elahi B, Elahi B, Chen R. Effect of Transcranial Magnetic Stimulation on Parkinson Motor Function-Systematic Review of Controlled Clinical Trials. MovDisord. 2009;24(3):357-363. doi: org/10.1002/mds.22364
  13. Fregni F, Simon DK, Wu A, Pascual-Leone A. Non-invasive brain stimulation for Parkinson’s disease: a systematic review and meta-analysis of the literature. J Neurol Neurosurg Psychiatry. 2005;76(12):1614-1623.
  14. Pascual-Leone A, Valls-Solé J, Brasil-Neto JP, Cammarota A, Grafman J, Hallett M. Akinesia in Parkinson’s disease, II: effects of subthreshold repetitive transcranial motor cortex stimulation. Neurology. 1994;44(5):892-898. doi: org/10.1212/wnl.44.5.892
  15. Hallett M. Transcranial magnetic stimulation: a primer. Neuron. 2007;55(2):187-199. doi: org/10.1016/j.neuron.2007.06.026
  16. Reithler J, Peters JC, Sack AT. Multimodal transcranial magnetic stimulation: using concurrent neuroimaging to reveal the neural network dynamics of noninvasive brain stimulation. Prog Neurobiol. 2011;94(2):149-165. doi: org/10.1016/j.pneurobio.2011.04.004
  17. Rossi S, Hallett M, Rossini PM, Pascual-Leone A. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009;120(12):2008-2039. doi: 10.1016/j.clinph.2009.08.016
  18. Rossi S, Hallett M, Rossini PM, Pascual-Leone A,and The Safety of TMS Consensus Group Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. Author manuscript; available in PMC 2012 Jan 18. Published in final edited form as. Clin Neurophysiol. 2009;120(12):2008-2039. Published online 2009 Oct 14. doi: 10.1016/j.clinph.2009.08.016
  19. Terao Y, Ugawa Y. Basic mechanisms of TMS. J Clin Neurophysiol. 2002;19(4):322-343. doi: org/10.1097/00004691-200208000-00006
  20. Wagner T, Valero-Cabre A, Pascual-Leone A. Noninvasive human brain stimulation. Annu Rev Biomed Eng. 2007;9:527-65. doi: org/10.1146/annurev.bioeng.9.061206.133100
  21. Allen EA, Pasley BN, Duong T, Freeman RD. Transcranial magnetic stimulation elicits coupled neural and hemodynamic consequences. Science. 2007;317(5846):1918-1921.
  22. Cho SS, Strafella AP. rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex. PLoS One. 2009;4(8):6725. doi: 10.1371/journal.pone.0006725
  23. Strafella AP, Vanderwerf Y, Sadikot AF. Transcranial magnetic stimulation of the human motor cortex influences the neuronal activity of subthalamic nucleus. Eur J Neurosci. 2004;20(8):2245-2249. doi:org/10.1111/j.1460-9568.2004.03669.x
  24. Machado S, Arias-Carrión O, Paes F, Vieira RT, Caixeta L, Novaes F, Marinho T, Almada LF, Silva AC, Egidio A. Nardi Repetitive Transcranial Magnetic Stimulation for Clinical Applications in Neurological and Psychiatric Disorders. AnOverview Eurasian J Med. 2013;45(3):191-206. doi: 10.5152/eajm.2013.39
  25. Cardenas-Morales M, Gron G, Kammer T. Exploring the after-effects of theta burst magnetic stimulation on the human motor cortex: A functional imaging study. Hum Brain Mapp. 2011;32:1948-1960. doi: org/10.1002/hbm.21160
  26. Kandler RH, Jarratt JA, Sagar HJ, Gumpert EJ, Venables GS, Davies-Jones GA, Jordan N. Abnormalities of central motor conduction in Parkinson’s disease. J Neurol Sci. 1990;100(1-2):94-97. doi: org/10.1016/0022-510x(90)90018-i
  27. Cantelo R, Tarletti R, Civardi C. Transcranial magnetic stimulation and Parkinson’s disease. Brain Res Rev. 2002;38:309-327. doi: org/10.1016/s0165-0173(01)00158-8
  28. Strafella AP, Valzania F, Nassetti SA, Tropeani A, Bisulli A, Santangelo M, Tassinari CA. Effects of chronic levodopa and pergolide treatment on cortical excitability in patients with Parkinson’s disease: a transcranial magnetic stimulation study. Clin Neurophysiol. 2000;111(7):1198-1202. doi: org/10.1016/s1388-2457(00)00316-3
  29. Benninger DH, Iseki K, Sarah K, Luckenbaugh DA, Houdayer E, Hallett M. Controlled Study of 50 Hz Repetitive Transcranial Magnetic Stimulation for the Treatment of Parkinson’s Disease Mark Hallett Neurorehabil Neural Repair. Author manuscript; available in PMC 2014 Sep 21. Published in final edited form as: Neurorehabil Neural Repair. 2012;26(9):1096-1105. Published online 2012 May 15. doi: 10.1177/1545968312445636
  30. Chou YH, Hickey PT, Sundman M, Song AW, Chen NK. Effects of repetitive transcranial magnetic stimulation on motor symptoms in Parkinson disease: a systematic review and meta-analysis. JAMA Neurol. 2015;72(4):432-440. doi: 10.1001/jamaneurol.2014.4380
  31. Siebner HR, Bergmann TO, Bestmann S, Massimini M, Johansen-Berg H, Mochizuki H, Bohning DE, Boorman ED, Groppa S, Miniussi C, Pascual-Leone A, Huber R, Taylor PC, Ilmoniemi RJ, De Gennaro L, Strafella AP, Kähkönen S, Klöppel S, Frisoni GB, George MS, Hallett M, Brandt SA, Rushworth MF, Ziemann U, Rothwell JC, Ward N, Cohen LG, Baudewig J, Paus T, Ugawa Y, Rossini PM. Consensus paper: combining transcranial stimulation with neuroimaging. BrainStimul. 2009;2:58-80. doi: org/10.1016/j.brs.2008.11.002
  32. Boylan LS, Pullman SL, Lisanby SH, Spicknall KE, Sackeim HA. Repetitive transcranial magnetic stimulation to SMA worsens complex movements in Parkinson’s disease. Clin Neurophysiol. 2001;112(2):259-264. doi: org/10.1016/s1388-2457(00)00519-8
  33. Okabe S, Ugawa Y, Kanazawa I. 0.2-Hz repetitive transcranial magnetic stimulation has no add-on effects as compared to a realistic sham stimulation in Parkinson’s disease. Mov Disord. 2003;18(4):382-388. doi:org/10.1002/mds.10370
  34. Chen R, Kumar S, Garg RR, Lang AE. Impairment of motor cortex activation and deactivation in Parkinson’s disease. Clin Neurophysiol. 2001;112(4):600-607. doi: org/10.1016/s1388-2457(01)00466-7
  35. Fitzgerald PB, Fountain S, Daskalakis ZJ. A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition. Clin Neurophysiol. 2006;117(12):2584-2596.
  36. Abraham G. Combined transcranial magnetic stimulation and right unilateral electroconvulsive therapy in patients with treatment-refractory depression. Can J Psychiatry. 2004;49(6):412.
  37. Morari M, Marti M, Sbrenna S, Fuxe K, Bianchi C, Beani L. Reciprocal dopamine-glutamate modulation of release in the basal ganglia. Neurochem Int. 1998;33(5):383-397. doi: org/10.1016/s0197-0186(98)00052-7
  38. Lefaucheur JP. Myoclonus and transcranial magnetic stimulation. Myoclonus and transcranial magnetic stimulation. Neurophysiol Clin. 2006;36(5-6):293-297. doi: org/10.1016/j.neucli.2006.12.008
  39. Goldman JG, Postuma R. Premotor and non-motor features of Parkinsons disease. Curr Opin Neurol. Author manuscript; available in PMC 2015 Aug 1. Published in final edited form as. Curr Opin Neurol. 2014;27(4):434-441. doi: 10.1097/WCO.0000000000000112
  40. Seppi K, Weintraub D, Coelho M, Perez-Lloret S, Fox SH, Katzenschlager R, Hametner EM, Poewe W, Rascol O, Goetz CG, Sampaio C. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson’s disease. Mov Disord. 2014;26(suppl 3):42-80. doi: 10.1002/mds.23884
  41. Akhmadeeva G.N., Tayupova G.N., Baitimerov A.R., Magzhanov R.V., Khidiyatova I.M., Khusnutdinova E.K. Izuchenie vozmozhnykh faktorov riska vozniknoveniya trevozhno-depressivnykh narushenii u patsientov s bolezn'yu Parkinsona v Respublike Bashkortostan. Nevrologicheskii vestnik im. V.M. Bekhtereva. 2015;1:27-31.
  42. Starkstein SE, Merello M, Jorge R, Brockman S, Bruce D, Petracca G, Robinson RG. A validation study of depressive syndromes in Parkinson’s disease. Mov Disord. 2008;23(4):538-546. doi: org/10.1002/mds.21866
  43. Storch A, Schneider CB, Wolz M, Stürwald Y, Nebe A, Odin P, Mahler A, Fuchs G, Jost WH, Chaudhuri KR, Koch R, Reichmann H, Ebersbach G. Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications. Neurology. 2013;80(9):800-809. doi: 10.1212/WNL.0b013e318285c0ed
  44. Dragasevic N, Potrebic A, Damjanovic A, Stefanova E, Kostic VS. Therapeutic efficacy of bilateral prefrontal slow repetitive transcranial magnetic stimulation in depressed patients with Parkinson’s disease: an open study. Mov Disord. 2002;17:528-532. doi: 10.1002/mds.10109
  45. Hizli Sayar G, Ozten E, Tan O, Tarhan N. Transcranial magnetic stimulation for treating depression in elderly patients. Neuropsychiatr Dis Treat. 2013;9:501-504. doi: 10.2147/NDT.S44241
  46. Fregni F, Santos CM, Myczkowski ML, Rigolino R, Gallucci-Neto J, Barbosa ER, Valente KD, Pascual-Leone A, Marcolin MA. Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2004;75:1171-1174. doi: 10.1136/jnnp.2003.027060
  47. Pal E, Nagy F, Aschermann Z, Balazs E, Kovacs N. The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson’s disease: a randomized, double-blind, placebo-controlled study. Mov Disord. 2010;25:2311-2317. doi: 10.1002/mds.23270
  48. Cattaneo Z, Rota F, Walsh V, Vecchi T, Silvanto J. TMS-adaptation reveals abstract letter selectivity in the left posterior parietal cortex. Cereb Cortex. 2009;19:2321-2325. doi: org/10.1093/cercor/bhn249
  49. Chen R, Classen J, Gerloff C, Celnik P, Wassermann EM, Hallett M, Cohen LG. Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology. 1997;48:1398-1403. doi: org/10.1212/wnl.48.5.1398
  50. Benninger DH, Berman BD, Houdayer E, Pal N, Luckenbaugh DA, Schneider L, Miranda S, Hallett M. Intermittent θ-burst transcranial magnetic stimulation for treatment of Parkinson disease. Neurology. 2011;76:601-609. doi: 10.1212/WNL.0b013e31820ce6bb.10.1212/WNL.0b013e31820ce6bb
  51. Ikeguchi M, Touge T, Nishiyama Y, Takeuchi H, Kuriyama S, Ohkawa M. Effects of successive repetitive transcranial magnetic stimulation on motor performances and brain perfusion in idiopathic Parkinson’s disease. J Neurol Sci. 2003;209(1-2):41-46. doi: org/10.1016/s0022-510x(02)00459-8
  52. Solé-Padullés C, Bartrés-Faz D, Junqué C, Clemente IC, Molinuevo JL, Bargalló N, Sánchez-Aldeguer J, Bosch B, Falcón C, Valls-Solé J. Repetitive transcranial magnetic stimulation effects on brain function and cognition among elders with memory dysfunction: a randomized sham-controlled study. Cereb Cortex. 2006;16:1487-1493. doi: 10.1093/cercor/bhj083
  53. Benninger DH, Lomarev M, Lopez G, Wassermann EM, Li X, Considine E, Hallett M. Transcranial direct current stimulation for the treatment of Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2010;81:1105-1111. doi: 10.1136/jnnp.2009.202556
  54. Boggio PS, Fregni F, Bermpohl F, Mansur CG, Rosa M, Rumi DO, Barbosa ER, Odebrecht Rosa M, Pascual-Leone A, Rigonatti SP, Marcolin MA, Araujo Silva MT. Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson’s disease and concurrent depression. Mov Disord. 2005;20:1178-1184. doi: org/10.1002/mds.20508
  55. Boggio PS, Ferrucci R, Rigonatti SP, Covre P, Nitsche M, Pascual-Leone A, Fregni F. Effects of transcranial direct current stimulation on working memory in patients with Parkinson’s disease. J Neurol Sci. 2006;249:31-38. doi: 10.1016/j.jns.2006.05.062
  56. Cardoso EF, Fregni F, Maia FM, Boggio PS, Luis Myczkowski ML, Coracini K, Lopes Vieira A, Melo LM, Sato JR, Marcolin MA, Rigonatti SP, Cruz AC Jr, Reis Barbosa E, Amaro E Jr. rTMS treatment for depression in Parkinson’s disease increases BOLD responses in the left prefrontal cortex. Int J Neuropsychopharmacol. 2008;11:173-183. doi: 10.1017/S1461145707007961
  57. Epstein CM, Evatt ML, Funk A, Girard-Siqueira L, Lupei N, Slaughter L, Athar S, Green J, McDonald W, DeLong MR. An open study of repetitive transcranial magnetic stimulation in treatment-resistant depression with Parkinson’s disease. Clin Neurophysiol. 2007;118:2189-2194. doi: 10.1016/j.clinph.2007.07.010
  58. Fregni F, Ono CR, Santos CM, Bermpohl F, Buchpiguel C, Barbosa ER, Marcolin MA, Pascual-Leone A, Valente KD. Effects of antidepressant treatment with rTMS and fluoxetine on brain perfusion in PD. Neurology. 2006;66:1629-1637. doi: 10.1212/01.wnl.0000218194.12054.60
  59. Furukawa T, Izumi S, Toyokura M, Masakado Y. Effects of low-frequency repetitive transcranial magnetic stimulation in Parkinson’s disease. Tokai J Exp Clin Med. 2009;34:63-71.
  60. Kormos TC. Efficacy of rTMS in the treatment of co-morbid anxiety in depressed patients with Parkinson’s disease. Mov Disord. 2007;22:1836. doi: 10.1002/mds.21613
  61. Elder GJ, Taylor JP. Transcranial magnetic stimulation and transcranial direct current stimulation: treatments for cognitive and neuropsychiatric symptoms in the neurodegenerative dementias? Alzheimers Res Ther. 2014;6(9):74. doi: 10.1186/s13195-014-0074-1
  62. Hamidi M, Johnson JS, Feredoes E, Postle BR. Does high-frequency repetitive transcranial magnetic stimulation produce residual and/or cumulative effects within an experimental session? Brain Topogr. 2011;23:355-367. doi: org/10.1007/s10548-010-0153-y
  63. Hannula H, Neuvonen T, Savolainen P, Hiltunen J, Ma YY, Antila H, Salonen O, Carlson S, Pertovaara A. Increasing top-down suppression from prefrontal cortex facilitates tactile working memory. Neuro Image. 2010;49:1091-1098. doi: org/10.1016/j.neuroimage.2009.07.049
  64. Hayward G, Goodwin GM, Harmer CJ. The role of the anterior cingulate cortex in the counting Stroop task. Exp Brain Res. 2004;154:355-358. doi: org/10.1007/s00221-003-1665-4
  65. Herwig U, Abler B, Schönfeldt-Lecuona C, Wunderlich A, Grothe J, Spitzer M, Walter H. Verbal storage in a premotor-parietal network: evidence from fMRI-guided magnetic stimulation. NeuroImage. 2003;20:1032-1041. doi: org/10.1016/s1053-8119(03)00368-9
  66. Hilgetag CC, Hugo T, Pascual-Leone A. Enhanced visual spatial attention ipsilateral to rTMS-induced ‘virtual lesons’ of human parietal cortex. NatNeurosci. 2001;4(9):953-957. doi: org/10.1038/nn0901-953
  67. Homan RW, Herman J, Purdy P. Cerebral location of international 10-20 system electrode placement. Electroencephalogr Clin Neurophysiol. 1987;66:376-382. doi: org/10.1016/0013-4694(87)90206-9
  68. Iriki A, Pavlides C, Keller A, Asanuma H. Long-term potentiation in the motor cortex. Science. 1989;245:1385-1387. doi: org/10.1126/science.2551038
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.